Bresser, Philppa LynnSathekge, Mike MachabaVorster, Mariza2023-07-182023-07-182022-07Bresser, P.L., Sathekge, M.M. & Vorster, M. 2022, 'PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study', Nuclear Medicine Communications, vol. 43, no. 7, pp. 787-793, doi : 10.1097/MNM.0000000000001580.0143-3636 (print)1473-5628 (online)10.1097/MNM.0000000000001580http://hdl.handle.net/2263/91507en© 2022 Wolters Kluwer Health, Inc. All rights reserved. This is a non-final version of an article published in final form in Nuclear Medicine Communications, vol. 43, no. 7, pp. 787-793, doi : 10.1097/MNM.0000000000001580.68Ga-nitroimidazole PET/CTHypoxiaPositron emission tomography/computed tomography (PET/CT)Tuberculosis (TB)SDG-03: Good health and well-beingPET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis : a proof-of-concept studyPostprint Article